At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
NTI-tss +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device: Overview and Results of a Placebo-Controlled Crossover Study
In Brief
A clinical study evaluating NTI-tss and Placebo for Chronic Migraine, Headache. Completed, enrolled 25 participants across 1 site.
Detailed Summary
Single blinding study comparing FDA cleared device for prevention of medically diagnosed migraine pain to placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Migraine, Headache
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
Primary CompletionJun 2020
First PostedMay 2021
TodayJul 2026
First PostedMay 4, 2021
Enrollment StartOct 1, 2019
Primary CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.2 years ago
Interventions
NTI-tssdevice
FDA cleared device for prophylactic treatment of medically diagnosed migraine pain
Placebodevice
Similar to Device, but having no influence on clenching intensity